Direct-Double-Differential PCR for Gene Dosage Quantification of c-myc, Alf Beckmann, 1, 4 Ulf Vogt, 2 Norbert Huda, 3 Kurt S. Zänker, 4 and Burkhard H. Brandt c-myc gene amplification that leads to overexpression has been shown to play a major role in cancer development, especially in breast cancer (1) . Two methodological approaches based on PCR, differential PCR (2) and competitive PCR (3), have been developed for gene dosage quantification and have been applied to c-myc. When these methods are used, both degraded DNA and the necessarily low competitor concentrations, which are prone to dilution errors, lead to over-or underestimation of gene dosages. Methods using separate comparisons of two single-copy reference genes for any DNA sample (double-differential PCR) (4, 5) , dilution series of the competitors (competitive-differential PCR) (6), or sample DNA (in differential PCR) (7) have been introduced to quantitative PCR to circumvent those problems. In consequence, the methods are labor-intensive, time-consuming, and expensive.
We improved quantitative PCR and developed a reliable and sensitive direct-double-differential PCR method for c-myc gene dosage quantification in which DNA fragments of two different single-copy reference genes, manganese superoxide dismutase (SOD2) and ␤-globin (HBB), and the target DNA fragment (c-myc) are coamplified simultaneously in one reaction tube. The c-myc PCR product (110 bp) is bracketed by the SOD2 (90 bp) and HBB (252 bp) PCR fragments in length. Sequences were exponentially amplified using 40 ng of sample DNA in a 50-L reaction volume under the following reaction conditions: denaturation at 94°C for 3 min; followed by 25 cycles of denaturation for 1 min at 94°C, annealing for 1 min at 62°C, and extension for 1 min 72°C; and a final extension step of 7 min at 72°C.
To exclude incorrect gene dosage quantification caused by varying PCR reactant concentrations (8) , all PCR components [10 pmol of primer (shown in Table 1 ); a downstream primer labeled fluorescently with 6-carboxy-fluorescein (FAM; Biometra); 0.3 L of Taq DNA Polymerase and 1ϫ Taq reaction buffer with MgCl 2 (Pharmacia); and 200 mol each of GeneAmp ® dNTPs (Perkin-Elmer)] were premixed and applied to equal amounts of patient DNA, leukocyte DNA, and a highcopy DNA sample from SK-BR-3 cells. Formalin fixation, paraffin embedding, isolation, and long-term storage of DNA are associated with DNA fragmentation. In addition, PCR product yield is inversely correlated to amplicon length, especially in degraded DNA (9) . Therefore, the peak area of a single-copy c-myc gene dosage was calculated by using the length and peak areas obtained from Genescan TM 2.1 evaluation software (Perkin-Elmer) of the two control fragments (Fig. 1, A and B) as two points on a line. This line allowed the determination of the peak area of the single-copy gene (A c-myc single-copy gene ) at the length of the c-myc amplicon (Fig. 1C) as described in Eq. 1. where L SOD2 is the length of SOD2 in base pairs; L HBB is the length of HBB in base pairs; L c-myc is the length of c-myc in base pairs; A HBB is the peak area of HBB; and A SOD2 is the peak area of SOD2. The gene dosage was obtained by dividing the detected peak area (A c-myc det ) by the calculated peak area (A c-myc single-copy gene ) of the c-myc PCR product (Eq. 2).
Gene dosage ϭ
A c-myc det A c-myc single-copy gene (2) The accuracy of our method was tested in 10 independent analyses of leukocyte DNA, which revealed an average gene dosage of 1.12 (n ϭ 10; range, 1.03-1.16; CV ϭ 4%). When we used degraded leukocyte DNA (as documented by agarose gel electrophoresis), our method exhibited a gene dosage for the c-myc gene of 1.08 (n ϭ 3; range, 0.97-1.14; CV ϭ 7%), which facilitates the gene dosage quantification of highly degraded DNA such as DNA in plasma or paraffin-embedded tissue. Examples of singlecopy and increased c-myc gene dosages are shown in Fig.  1 , A and B. When we applied this method to the analysis of c-myc gene dosages of breast cancer patients as well as to the breast cancer cell line SK-BR-3, we could detect a two-to fourfold increase of the c-myc gene copy number in 3 of 20 cases and a 10-fold increase of the c-myc gene copy number in SK-BR-3 (n ϭ 3; range, 9.31-10.26; CV ϭ 4%), which is in agreement with data in the literature (1, 10) . This method, which uses two control amplicons in combination with standardized laser-induced capillary electrophoresis, allows fast, reliable, and sensitive quantification of gene dosages without the use of synthetic competitors, even in the presence of highly degrade DNA.
